Found: 17
Select item for more details and to access through your institution.
Pharmacokinetics and Safety of CSL112 (Apolipoprotein A‐I [Human]) in Adults With Moderate Renal Impairment and Normal Renal Function.
- Published in:
- Clinical Pharmacology in Drug Development, 2019, v. 8, n. 5, p. 628, doi. 10.1002/cpdd.618
- By:
- Publication type:
- Article
ApoA-I Infusion Therapies Following Acute Coronary Syndrome: Past, Present, and Future.
- Published in:
- Current Atherosclerosis Reports, 2022, v. 24, n. 7, p. 585, doi. 10.1007/s11883-022-01025-7
- By:
- Publication type:
- Article
Phagocytosing macrophages exclude proteins from the zones of contact with opsonized targets.
- Published in:
- Nature, 1984, v. 309, n. 5966, p. 359, doi. 10.1038/309359a0
- By:
- Publication type:
- Article
Pharmacometric analyses to characterize the effect of CSL112 on apolipoprotein A‐I and cholesterol efflux capacity in acute myocardial infarction patients.
- Published in:
- British Journal of Clinical Pharmacology, 2021, v. 87, n. 6, p. 2558, doi. 10.1111/bcp.14666
- By:
- Publication type:
- Article
NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals.
- Published in:
- 2010
- By:
- Publication type:
- Correction Notice
NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals.
- Published in:
- Nature, 2010, v. 464, n. 7293, p. 1357, doi. 10.1038/nature08938
- By:
- Publication type:
- Article
Cyclodextrin promotes atherosclerosis regression via macrophage reprogramming.
- Published in:
- Science Translational Medicine, 2016, v. 8, n. 333, p. 1, doi. 10.1126/scitranslmed.aad6100
- By:
- Publication type:
- Article
Reconstituted high-density lipoprotein can elevate plasma alanine aminotransferase by transient depletion of hepatic cholesterol: role of the phospholipid component.
- Published in:
- Journal of Applied Toxicology, 2016, v. 36, n. 8, p. 1038, doi. 10.1002/jat.3264
- By:
- Publication type:
- Article
Infusion of Reconstituted High-Density Lipoprotein, CSL112, in Patients With Atherosclerosis: Safety and Pharmacokinetic Results From a Phase 2a Randomized Clinical Trial.
- Published in:
- 2015
- By:
- Publication type:
- journal article
A multiple ascending dose study of CSL112, an infused formulation of ApoA-I.
- Published in:
- Journal of Clinical Pharmacology, 2014, v. 54, n. 3, p. 301, doi. 10.1002/jcph.194
- By:
- Publication type:
- Article
CSL112 (Apolipoprotein A-I [Human]) Strongly Enhances Plasma Apoa-I and Cholesterol Efflux Capacity in Post-Acute Myocardial Infarction Patients: A PK/PD Substudy of the AEGIS-I Trial.
- Published in:
- Journal of Cardiovascular Pharmacology & Therapeutics, 2022, v. 27, p. 1, doi. 10.1177/10742484221121507
- By:
- Publication type:
- Article
Reconstituted HDL Elicits Marked Changes in Plasma Lipids Following Single-Dose Injection in C57Bl/6 Mice.
- Published in:
- Journal of Cardiovascular Pharmacology & Therapeutics, 2012, v. 17, n. 3, p. 315, doi. 10.1177/1074248411426144
- By:
- Publication type:
- Article
Moderate Renal Impairment Does Not Impact the Ability of CSL112 (Apolipoprotein A‐I [Human]) to Enhance Cholesterol Efflux Capacity.
- Published in:
- Journal of Clinical Pharmacology, 2019, v. 59, n. 3, p. 427, doi. 10.1002/jcph.1337
- By:
- Publication type:
- Article
Immunochemotherapy for Intracellular Leishmania donovani Infection: γ Interferon Plus Pentavalent Antimony.
- Published in:
- Journal of Infectious Diseases, 1988, v. 157, n. 5, p. 973, doi. 10.1093/infdis/157.5.973
- By:
- Publication type:
- Article
Evaluation of potential antiplatelet effects of CSL112 (Apolipoprotein A-I [Human]) in patients with atherosclerosis: results from a phase 2a study.
- Published in:
- Journal of Thrombosis & Thrombolysis, 2018, v. 45, n. 4, p. 469, doi. 10.1007/s11239-018-1644-z
- By:
- Publication type:
- Article
The involvement of CD14 in stimulation of cytokine production by uronic acid polymers.
- Published in:
- European Journal of Immunology, 1993, v. 23, n. 1, p. 255, doi. 10.1002/eji.1830230140
- By:
- Publication type:
- Article
Innate recognition of bacterial LPS.
- Published in:
- Innate Immunity, 1999, v. 5, n. 3, p. 178, doi. 10.1177/09680519990050030302
- By:
- Publication type:
- Article